30 March 2023

The Department of Obstetrics and Gynecology established the EVA trial biobank with the aim of enabling scientific research into high blood pressure in pregnancy to improve the diagnosis, treatment and prognosis of patients in the future. The EVA trial biobank contains biomaterial (serum, EDTA- and citrate plasma) and specific data from the participating patient’s medical record.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


National Biobanks & Collections day

19 October 2023

The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.

read more

Quality certificate for the PBMC isolation method and cfDNA extraction method

8 August 2023

Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.

read more

TETRO-trial

30 March 2023

The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.

read more

Archipelago

30 March 2023

Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.

read more

Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard

30 March 2023

In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.

read more

Health-RI receives definitive follow-up funding from the National Growth Fund

30 March 2023

The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.

read more